Back
The Goldman Sachs Group Vs. Corbus Pharmaceuticals Holdings Industry Stock Comparison
Buy
78
GS
The Goldman Sachs Group
Last Price:
427.01
Seasonality Move:
1.49%
Sell
45
CRBP
Corbus Pharmaceuticals Holdings
Last Price:
34.39
Seasonality Move:
-9.19%
Buy
78
The Goldman Sachs Group (GS)
is a Buy
Is The Goldman Sachs Group a Buy, Sell or Hold?
- The current The Goldman Sachs Group [GS] share price is $427.57. The Score for GS is 78, which is 56% above its historic median score of 50, and infers lower risk than normal.
- GS is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
45
Corbus Pharmaceuticals Holdings (CRBP)
is a Sell
Is Corbus Pharmaceuticals Holdings a Buy, Sell or Hold?
- The current Corbus Pharmaceuticals Holdings [CRBP] share price is $34.25. The Score for CRBP is 45, which is 10% below its historic median score of 50, and infers higher risk than normal.
- CRBP is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
GS Stock Price Chart
What is The Goldman Sachs Group's stock price today?
-
The The Goldman Sachs Group share price today is $427.57
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and GS is experiencing buying pressure, which is a positive indicator for future bullish movement.
CRBP Stock Price Chart
What is Corbus Pharmaceuticals Holdings's stock price today?
-
The Corbus Pharmaceuticals Holdings share price today is $34.25
The current trend is moderately bearish and CRBP is experiencing buying pressure, which is a positive indicator for future bullish movement.
GS Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 6.02 | Buy |
| Relative Strength Index (14 RSI): | 65.45 | Buy |
| Chaikin Money Flow: | 1805806 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (400.26 - 418.34) | Buy |
| Bollinger Bands (100): | (371.69 - 405.29) | Buy |
CRBP Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.27 | Sell |
| Relative Strength Index (14 RSI): | 43.27 | Sell |
| Chaikin Money Flow: | 61510 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (35.63 - 40.09) | Sell |
| Bollinger Bands (100): | (9.33 - 38.21) | Buy |
GS Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 415.38 | Buy |
| 20-day SMA: | 409.09 | Buy |
| 50-day SMA: | 399.64 | Buy |
| 200-day SMA: | 358.46 | Buy |
| 8-day EMA: | 417.24 | Buy |
| 20-day EMA: | 410.26 | Buy |
| 50-day EMA: | 400.66 | Buy |
| 200-day EMA: | 369.43 | Buy |
CRBP Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 36.43 | Sell |
| 20-day SMA: | 38.25 | Sell |
| 50-day SMA: | 36.25 | Sell |
| 200-day SMA: | 14.94 | Buy |
| 8-day EMA: | 36.28 | Sell |
| 20-day EMA: | 37.41 | Sell |
| 50-day EMA: | 34.26 | Sell |
| 200-day EMA: | 19.79 | Buy |
The Goldman Sachs Group Earnings Growth & GS Earnings Dates
- Analysts estimate an earnings increase this quarter of $3.24 per share, an increase next quarter of $1.13 per share, an increase this year of $13.62 per share, and an increase next year of $3.47 per share.
Corbus Pharmaceuticals Holdings Earnings Growth & CRBP Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.69 per share, a decrease next quarter of $0.00 per share, an increase this year of $5.66 per share, and an increase next year of $0.09 per share.
The Goldman Sachs Group Technical Analysis
| Apr 15 | Apr 16 | Apr 17 | Apr 18 | Apr 19 | Apr 22 | Apr 23 | Apr 24 | Apr 25 | Apr 26 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | ||||||||||
| 15 | 16 | 17 | 18 | 19 | 22 | 23 | 24 | 25 | 26 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Corbus Pharmaceuticals Holdings Technical Analysis
| Apr 15 | Apr 16 | Apr 17 | Apr 18 | Apr 19 | Apr 22 | Apr 23 | Apr 24 | Apr 25 | Apr 26 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | ||||||||||
| 15 | 16 | 17 | 18 | 19 | 22 | 23 | 24 | 25 | 26 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||